Recovery of ovarian function by human embryonic stem cell-derived mesenchymal stem cells in cisplatin-induced premature ovarian failure in mice
Clicks: 170
ID: 273537
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
170 views
43 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #11 of 12 articles by views in stem cell research & therapy
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
hESC-MSC restored structure and function in the cisplatin-damaged ovary. Our study provides new insights into the great clinical potential of human hESC-MSC in treating POF.
| Reference Key |
sy2020stemrecovery
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Yoon SY;Yoon JA;Park M;Shin EY;Jung S;Lee JE;Eum JH;Song H;Lee DR;Lee WS;Lyu SW;; |
| Journal | stem cell research & therapy |
| Year | 2020 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
Mice
animals
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
female
pmid:32586410
pmc7318510
doi:10.1186/s13287-020-01769-6
sook young yoon
jung ah yoon
sang woo lyu
cisplatin / toxicity
human embryonic stem cells*
mesenchymal stem cell transplantation*
mesenchymal stem cells*
primary ovarian insufficiency* / chemically induced
primary ovarian insufficiency* / therapy
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.